Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
230
-
Total 13F shares, excl. options
-
89,139,107
-
Shares change
-
-1,587,339
-
Total reported value, excl. options
-
$1,393,245,089
-
Value change
-
-$23,081,055
-
Put/Call ratio
-
60%
-
Number of buys
-
118
-
Number of sells
-
-85
-
Price
-
$15.63
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q1 2024
284 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q1 2024.
NovoCure Ltd - Common Stock (NVCR) has 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89,139,107 shares
of 111,111,111 outstanding shares and own 80.23% of the company stock.
Largest 10 shareholders include FMR LLC (16,063,968 shares), VANGUARD GROUP INC (10,023,981 shares), BlackRock Inc. (9,084,412 shares), Capital International Investors (8,864,092 shares), STATE STREET CORP (3,362,865 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,378,940 shares), Capital World Investors (2,308,215 shares), BAILLIE GIFFORD & CO (1,990,375 shares), MORGAN STANLEY (1,756,639 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,643,132 shares).
This table shows the top 230 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.